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Dear Reader
As we reach the final issue of the year for Drugs in R&D, we hope
that you have found the articles published throughout 2010 to be both
interesting and informative. This year saw Drugs in R&D being
transformed from subscription based to open access, making it the first
Adis journal to embrace the open-access model. The editors and pub-
lishing staff have appreciated the high quality of content contributed to
the journal this year and were pleased to see a 35% increase in the
Drugs in R&D ISI impact factor (IF) to 1.354.
The high quality of other Adis Journals was also recognized in the
new ISI IFs for 2009 with ten of our titles making strong IF gains over
2008. The most impressive gains were made by BioDrugs (IF 3.506;
up >55%), Drugs (IF 4.732; up >14%), and the American Journal of
Clinical Dermatology (IF 1.820; up >17%). The American Journal of
Cardiovascular Drugs, a newly tracked journal in 2009, received its first
IF (1.964) and was ranked #47 in the ‘Cardiac & Cardiovascular Sys-
tem’ category. Pediatric Drugs was accepted for inclusion in Current
Contents/Clinical Medicine and a Thompson ISI IF for the journal is
expected in 2013. This year, we also celebrated the 10th anniversary of
the American Journal of Clinical Dermatology making significant
contributions to the field of dermatology.
We would like to say a big thank you to all the authors who have
contributed articles to Drugs in R&D in the last 12 months. Without
their hard work and diligence we would not have been able to publish
the journal. The quality of published articles also reflects the signif-
icant time and effort dedicated by the peer reviewers, who ensure that
we continue to publish content of the highest possible standard. In
addition to the members of our Honorary Editorial Board, we would
like to thank the following individuals who acted as referees for articles
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We look forward to your continued support and keeping you up-to-
date with topical issues in the field of drug research in 2011. With best
wishes from the staff of Drugs in R&D and all at Adis, a Wolters
Kluwer business.
212
ª 2010 Adis Data Information BV. All rights reserved. Drugs R D 2010; 10 (4)
